Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Bristol-Myers and Infinity partner for trial of opdivo and IPI-549

Histopathology of urothelial carcinoma of the urinary bladder. Credit: KGH.

  • Bristol-Myers

Go Top